Eugene Felber

Statistics

Publications

Citations

150

H-Index

Active since

2008

Affiliations

Bristol-Myers Squibb (United States)(Current)

AstraZeneca (United States)

Eugene Felber is an author at Bristol-Myers Squibb (United States) specializing in pharmacoeconomics, cost-effectiveness modeling, and glycemic control.

Publications per year

2008–2017

Publications

Retrospective Study of Adherence to Glucagon-like Peptide-1 Receptor Agonist Therapy in Patients with Type 2 Diabetes Mellitus in the United States

Stephen S. Johnston, Hiep Nguyen, Eugene Felber et al. · Advances in Therapy · 2014 · 71 citations

Medicine, Endocrinology, Internal Medicine +14

The Effect of Community‐Level Unemployment on Preventive Oral Health Care Utilization

Brian Quinn, Ralph Catalano, Eugene Felber · Health Services Research · 2008 · 37 citations · Full text

Dentistry, Preventive Dentistry, Preventive Medicine +17

Cost-effectiveness analysis of second-line tyrosine kinase inhibitor treatment for chronic myelogenous leukemia

John Whalen, Ipek Özer Stillman, Apoorva Ambavane et al. · Journal of Medical Economics · 2015 · 17 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +13

The Short-Term Cost-Effectiveness of Once-Daily Liraglutide Versus Once-Weekly Exenatide for the Treatment of Type 2 Diabetes Mellitus in the United States

Bruce Wang, Joshua A. Roth, Hiep Nguyen et al. · PLoS ONE · 2015 · 15 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacology +17

Real world treatment patterns in chronic myeloid leukemia patients newly initiated on tyrosine kinase inhibitors in an U.S. integrated healthcare system

Nazia Rashid, Han Koh, Kathy Lin et al. · Journal of Oncology Pharmacy Practice · 2017 · 10 citations

Medicine, Oncology, Pharmacology +13

1–5 of 5